Ultragenyx Pharmaceutical, Inc. (RARE)
23.39
+0.35
(+1.52%)
USD |
NASDAQ |
Feb 27, 16:00
22.66
-0.73
(-3.12%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Research and Development Expense (TTM) : 714.72M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Johnson & Johnson | 14.72B |
| CorMedix, Inc. | 12.46M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| BioMarin Pharmaceutical, Inc. | 700.97M |